Who Exports Levofloxacin from India — 699 Suppliers Behind a $72.1M Market
India's levofloxacin export market is supplied by 699 active exporters who collectively shipped $72.1M across 6,304 shipments. MACLEODS PHARMACEUTICALS LTD leads with a 13.2% market share, followed by MICRO LABS LIMITED and SENTISS PHARMA PRIVATE LIMITED. The top 5 suppliers together control 37.0% of total export value, reflecting a moderately competitive market structure.
Top Levofloxacin Exporters from India — Ranked by Export Value
MACLEODS PHARMACEUTICALS LTD is the leading levofloxacin exporter from India, holding a 13.2% share of the $72.1M market across 6,304 shipments from 699 exporters. The top 5 suppliers — MACLEODS PHARMACEUTICALS LTD, MICRO LABS LIMITED, SENTISS PHARMA PRIVATE LIMITED, ZYPHER LIFESCIENCES PRIVATE LIMITED, MEDCELL PHARMA — collectively control 37.0% of total export value, indicating a competitive market. Individual shares are: MACLEODS PHARMACEUTICALS LTD (13.2%), MICRO LABS LIMITED (7.0%), SENTISS PHARMA PRIVATE LIMITED (6.5%), ZYPHER LIFESCIENCES PRIVATE LIMITED (5.2%), MEDCELL PHARMA (5.1%).
Top Levofloxacin Exporters from India
Ranked by export value · 699 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVORIDELEVOTOP 500MG TABLET[LEVOFLOXACINE TABLE | $9.5M | 34 | 13.2% |
| 2 | MICRO LABS LIMITED LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLELEVOMAC IV 1X100ML | $5.0M | 27 | 7.0% |
| 3 | SENTISS PHARMA PRIVATE LIMITED LEVOMAC IV 1X100MLDRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IVLEVOLET 500MG TABS N10 | $4.7M | 5 | 6.5% |
| 4 | ZYPHER LIFESCIENCES PRIVATE LIMITED LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVOBACT 500 - TAX INVOICE NO: 701208738 DT: 30.04.2024LEVOMED LEVOFLOXACIN INFUSION BP 500 MG/ | $3.7M | 1 | 5.2% |
| 5 | MEDCELL PHARMA LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVORIDELEVOFLOXACIN TABLETS 500MG (EACH FILM-CO | $3.7M | 5 | 5.1% |
| 6 | KUSUM HEALTHCARE PRIVATE LIMITED LEVOMAC IV 1X100MLDRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IVLEVOLET 500MG TABS N10 | $2.7M | 7 | 3.7% |
| 7 | ZYDUS LIFESCIENCES LIMITED LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLELEVOFLOXACIN TABLETS USP 750MG [1X20 PERPACK]LEVOFLOXACIN TABLETS USP 500 MG - 1 X 50 | $2.5M | 8 | 3.5% |
| 8 | DR.REDDY'S LABORATORIES LTD DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IVLEVOFLOXACIN TABLETS USP 750MG [1X20 PERPACK]LEVOLET 500MG TABS N10 | $2.2M | 4 | 3.0% |
| 9 | MACLEODS PHARMACEUTICALS LIMITED LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVORIDELEVOTOP 500MG TABLET[LEVOFLOXACINE TABLE | $1.5M | 19 | 2.1% |
| 10 | CIPLA LIMITED | $1.5M | 3 | 2.1% |
| 11 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVOBACT 500 - TAX INVOICE NO: 701208738 DT: 30.04.2024LEVOMED LEVOFLOXACIN INFUSION BP 500 MG/ | $1.3M | 4 | 1.8% |
| 12 | AJANTA PHARMA LIMITED LEVORUX (LEVOFLOXACIN INFUSION 500MG/100LEVOTOP 500MG TABLET[LEVOFLOXACINE TABLELAEKIT - LEVOFLOXACIN TABLETS USP 500 MG | $1.3M | 15 | 1.8% |
| 13 | WEXFORD LABORATORIES PRIVATE LIMITED | $1.1M | 7 | 1.5% |
| 14 | MSN LABORATORIES PRIVATE LIMITED LAEKIT - LEVOFLOXACIN TABLETS USP 500 MGLEVOBACT 500 )LEVOBACT-750 ( (LEVOFLOXACIN 750MG IH TA | $743.1K | 7 | 1.0% |
| 15 | ACULIFE HEALTHCARE PRIVATE LIMITED LEVOMAC IV 1X100MLLEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/TIGERON-500 TABLETS 1X5S | $722.7K | 15 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Levofloxacin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MACLEODS PHARMACEUTICALS LTD | Approved | Yes | Yes | Not verified | Facilities approved by US FDA, UK MHRA, and WHO. |
| CIPLA LIMITED | Warning Letter, November | Yes | Yes | Not verified | Received FDA warning letter in November 2023; facilities approved by US FDA, UK |
| DR. REDDY'S LABORATORIES LTD | Approved | Yes | Yes | Not verified | Facilities approved by US FDA, UK MHRA, and WHO. |
| AJANTA PHARMA LIMITED | Approved | Yes | Yes | Not verified | Facilities approved by US FDA, UK MHRA, and WHO. |
| MSN LABORATORIES PRIVATE LIMITED | Approved | Yes | Yes | Not verified | Facilities approved by US FDA, UK MHRA, and WHO. |
| ACULIFE HEALTHCARE PRIVATE LIMITED | Approved | Yes | Yes | Not verified | Facilities approved by US FDA, UK MHRA, and WHO. |
TransData Nexus reviewed the regulatory standing of 6 leading Levofloxacin exporters from India. 5 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 6 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Levofloxacin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturers, contributing significantly to the supply chain of antibiotics like Levofloxacin. Companies such as Dr. Reddy's Laboratories, headquartered in Hyderabad, are prominent players in this sector. Dr. Reddy's is recognized as one of the leading API manufacturers and suppliers globally for Levofloxacin Hemihydrate.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara belt in Gujarat is a major hub for pharmaceutical formulations. This region is home to numerous companies specializing in the production of finished dosage forms, including Levofloxacin tablets. For instance, SiNi Pharma, based in Ahmedabad, manufactures and exports Levofloxacin tablets, offering strengths of 250 mg and 500 mg. Additionally, Taj Pharma, operating from Vapi in Gujarat, is recognized as a leading manufacturer and exporter of Levofloxacin tablets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for pharmaceuticals. Mumbai, being a major commercial hub, houses several pharmaceutical companies with significant export operations. Cipla Limited, headquartered in Mumbai, is a notable example. Cipla is an Indian multinational pharmaceutical company that primarily focuses on developing medications to treat various medical conditions and has a substantial global presence.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. Baddi is recognized as Asia's biggest pharmaceutical hub, housing numerous companies that produce a wide range of pharmaceutical products.
5Sourcing Recommendations
- Engage with API Manufacturers in Hyderabad: Collaborate with established API producers like Dr. Reddy's Laboratories to ensure a consistent and high-quality supply of Levofloxacin APIs.
- Partner with Formulation Experts in Gujarat: Consider alliances with companies such as SiNi Pharma and Taj Pharma in the Ahmedabad-Vadodara region for the procurement of finished Levofloxacin products.
- Leverage Export Capabilities in Mumbai: Utilize the export infrastructure and expertise of Mumbai-based firms like Cipla Limited to facilitate international distribution of Levofloxacin products.
- Explore Manufacturing Opportunities in Baddi: Take advantage of the manufacturing facilities and tax benefits in the Baddi-Nalagarh region to optimize production costs for Levofloxacin formulations.
Common Questions — Levofloxacin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which levofloxacin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MACLEODS PHARMACEUTICALS LTD leads with 256 recorded shipments worth $9.5M. MICRO LABS LIMITED (365 shipments) and SENTISS PHARMA PRIVATE LIMITED (99 shipments) are also established high-volume exporters.
Q How many levofloxacin manufacturers are there in India?
India has 699 active levofloxacin exporters with a combined export market of $72.1M across 6,304 shipments to 150 countries. The top 5 suppliers hold 37.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for levofloxacin from India?
Average FOB unit price: $7.38 per unit, ranging from $0.00 to $1725.99. Average shipment value: $11.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 699 verified Indian exporters of Levofloxacin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 6,304 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 150 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,304 Verified Shipments
699 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists